STOCK TITAN

Viatris Maintains Dividend Policy for 2025 and Announces Quarterly Dividend

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
dividends

Viatris (NASDAQ: VTRS) has announced its dividend policy for 2025, maintaining an annual dividend of $0.48 per share. The company's Board of Directors has declared a quarterly dividend of $0.12 per share, payable on March 18, 2025, to shareholders of record as of March 10, 2025. This represents the company's fifth consecutive year of dividend payments, demonstrating continued commitment to shareholder returns.

Loading...
Loading translation...

Positive

  • Maintained stable dividend policy at $0.48 annual payout
  • 5-year track record of consistent dividend payments

Negative

  • No dividend increase for 2025

News Market Reaction

-15.21%
1 alert
-15.21% News Effect

On the day this news was published, VTRS declined 15.21%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

PITTSBURGH, Feb. 27, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that on February 24, 2025, its Board of Directors approved a 2025 dividend policy of 48 cents ($0.48) per share and declared a quarterly dividend of 12 cents ($0.12) for each issued and outstanding share of the Company's common stock. The dividend is payable on March 18, 2025, to shareholders of record at the close of business on March 10, 2025. This marks the fifth consecutive year the Company has paid a dividend.

About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedInInstagramYouTube and X (formerly Twitter).

Forward-Looking Statements
This press release includes statements that constitute "forward-looking statements." These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward looking statements may include statements regarding Viatris' 2025 dividend policy of 48 cents ($0.48) per share and Viatris declaring a quarterly dividend of 12 cents ($0.12) for each issued and outstanding share of the Company's common stock payable on March 18, 2025 to shareholders of record at the close of business on March 10, 2025. Because forward-looking statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: actions and decisions of healthcare and pharmaceutical regulators; our ability to comply with applicable laws and regulations; changes in healthcare and pharmaceutical laws and regulations in the U.S. and abroad; any regulatory, legal or other impediments to Viatris' ability to bring new products to market; Viatris' or its partners' ability to develop, manufacture, and commercialize products; the scope, timing and outcome of any ongoing legal proceedings, and the impact of any such proceedings; Viatris' failure to achieve expected or targeted future financial and operating performance and results; risks associated with international operations; changes in third-party relationships; the effect of any changes in Viatris' or its partners' customer and supplier relationships and customer purchasing patterns; the impacts of competition; changes in the economic and financial conditions of Viatris or its partners; uncertainties and matters beyond the control of management, including general economic conditions, inflation and exchange rates; and the other risks described in Viatris' filings with the Securities and Exchange Commission (SEC). Viatris routinely uses its website as a means of disclosing material information to the public in a broad, non-exclusionary manner for purposes of the SEC's Regulation Fair Disclosure (Reg FD). Viatris undertakes no obligation to update these statements for revisions or changes after the date of this press release other than as required by law.

Viatris OUS Logo (PRNewsfoto/Viatris Inc.)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-maintains-dividend-policy-for-2025-and-announces-quarterly-dividend-302386556.html

SOURCE Viatris Inc.

FAQ

What is Viatris (VTRS) dividend amount for 2025?

Viatris will pay a total annual dividend of $0.48 per share for 2025, distributed as quarterly payments of $0.12 per share.

When is the next VTRS dividend payment date in 2025?

The next Viatris dividend payment is scheduled for March 18, 2025, for shareholders of record as of March 10, 2025.

How long has VTRS been paying dividends?

Viatris has been paying dividends for five consecutive years as of 2025.

What is the dividend frequency for Viatris (VTRS) stock?

Viatris pays dividends quarterly, with each payment being $0.12 per share.
Viatris Inc Ord Shs

NASDAQ:VTRS

VTRS Rankings

VTRS Latest News

VTRS Latest SEC Filings

VTRS Stock Data

18.19B
1.15B
0.28%
85.61%
3.48%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CANONSBURG